EYPT:NASDAQ
EyePoint Inc
3,17 $
arrow_upward
+0,63%(+0,020) 1D
3,14 $
arrow_downward
-0,95% (-0,030)todayPre-market
Closed: 6 հոկ, 16:00:01 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EYPT...
Open
3,18 $
High
3,29 $
Low
3,08 $
Mkt. cap
281,97 մլն
Avg. vol.
3,63 մլն
Volume
442,00
52-wk high
19,11 $
52-wk low
3,05 $
EPS
-3,74 $
Beta
1,67
Shares outstanding
86,21 մլն
No. of employees
214
Open
3,18 $
High
3,29 $
Low
3,08 $
Mkt. cap
281,97 մլն
Avg. vol.
3,63 մլն
Volume
442,00
52-wk high
19,11 $
52-wk low
3,05 $
EPS
-3,74 $
Beta
1,67
Shares outstanding
86,21 մլն
No. of employees
214
News stories
From web sources and news partners
Stock Titan
·
1 ժամ առաջ
Five parties report an EyePoint (EYPT) stake but disclaim ownership of shares held by Managed Funds.
Investor's Business Daily
·
1 ամիս առաջ
The Surprising Reason This Biotech Just Plummeted 67%
STAT
·
1 ամիս առաջ
Eyepoint study results for vision treatment disappoint, but company still sees promise
https://www.dars.gov.et/
·
1 ամիս առաջ
EYPT Q2 2026 Earnings: Wider-than-Expected Loss, Shares Still Rise 3.68% - Operating Margin Analysis
Profile
EyePoint Pharmaceuticals Inc. is a Watertown, Massachusetts company specialising in the application of microelectromechanical systems and nanotechnology to drug delivery.
pSivida obtained porous silicon technology from the British government Defence Evaluation and Research Agency. QinetiQ continues to be a strategic partner.
In June 2004, pSivida acquired full ownership of pSiMedica. In April 2018, pSivida purchased eye products firm Icon Bioscience. Afterwards, it rebranded to its current name of EyepOint Pharmaceuticals, Inc. Wikipedia
About EyePoint Inc
CEO-
Employees214
Founded2000
HeadquartersՈւոթերթաուն, Մասսաչուսեթս, Միացյալ Նահանգներ
Sector-
Websiteeyepoint.bio